Evidence map›Paper›PMID 41433332›Full record

SynthesisPLoS neglected tropical diseases2025

Burden of scabies in displacement settings: A systematic review and meta-analysis among forcibly displaced populations.

Gelila Yitageasu, Angwach Abrham Asnake, Alemayehu Kasu Gebrehana, Bizunesh Fantahun Kase, Hiwot Altaye Asebe, Mitkie Tigabie, Lidetu Demoze

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gelila YitageasuDepartment of Environmental and Occupational Health and Safety, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.ORCID 0009-0009-7398-4956
Angwach Abrham AsnakeDepartment of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia.
Alemayehu Kasu GebrehanaDepartment of Midwifery, College of Health Sciences, Salale University, Fitche, Ethiopia.
Bizunesh Fantahun KaseDepartment of Public Health, College of Health Sciences, Mattu University, Mattu, Ethiopia.
Hiwot Altaye AsebeDepartment of Public Health, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.
Mitkie TigabieDepartment of Medical Microbiology, School of Biomedical and Laboratory Science, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Lidetu DemozeDepartment of Environmental and Occupational Health and Safety, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBy the end of 2024, an estimated 123.2 million people were forcibly displaced due to conflict and persecution, with 80% residing in low- and middle-income countries. Scabies, a neglected tropical disease affecting around 200 million people globally and causing over 455 million new cases annually, disproportionately affects displaced populations due to overcrowding, poor hygiene, and limited healthcare access. However, global evidence on its prevalence among these groups remains inconsistent. This study aimed to estimate the global pooled prevalence of scabies among forcibly displaced populations.

methodsSystematic searches were conducted in PubMed, Epistemonikos, ScienceDirect, Scopus, and Embase for studies published up to May 28, 2025, supplemented by hand-searches using Google and Google Scholar to capture any additional relevant studies. Data were extracted using Microsoft Excel 2021 and analyzed with STATA version 17. We conducted a systematic review and meta-analysis using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Only studies that met the predefined inclusion criteria were included. The Newcastle-Ottawa Scale assessed study quality. A random-effects model was used to calculate pooled prevalence. Heterogeneity was measured using the Galbraith plot and the I2 statistic, while publication bias with funnel plots and Egger's regression test. The protocol was registered with PROSPERO (CRD420251067217).

resultsFourteen studies with 76,664 participants were included. The global pooled prevalence of scabies was 15% (I2 = 99.87%). Prevalence varies by region, study setting, population group, and data collection method. Prevalence was highest in Asia (25%), followed by Europe (13%) and Africa (7%). Refugees showed the highest prevalence (23%), compared to IDPs (13%), asylum seekers (2%), and refugee-asylum seekers (2%). Among population groups, prevalence was highest in combined adult-child populations (66%), patients (24%), and school-aged children (15%), women and children under 15 years (6%), the general population (2%), and unaccompanied minors (1%). Studies using both clinical exams and Questionnaires reported a higher prevalence (27%) than those using clinical exams alone (14%) and interviews or physical examination only (3% and 2%, respectively).

conclusionScabies poses a significant health (15%) burden among forcibly displaced populations. Integrated interventions, including screening, treatment, WASH programs, and improved surveillance, are urgently needed to reduce transmission and improve health outcomes in displacement settings.

Indexed as

RefugeesScabiesGlobal HealthHumansPrevalence

Identifiers

PMID41433332
PMCPMC12725569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.